Heart Failure, CongestiveNCT07656428
Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized Patients
An observational study of Heart Failure, Congestive and Renal Failure Acute Chronic, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
This research project aims to establish a real-time focused ultrasound examination protocol for routine assessment of hospitalized patients, including evaluations of the inferior vena cava (IVC), pericardial effusion, hydronephrosis, and ascites. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure, Congestive, Renal Failure Acute Chronic, Liver Cirrhosis
- How many people
- 9,000 participants
- Where
- 1 siteTaiwan
- Study dates
- 5 Apr 2025to 5 Apr 2035
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Hospitalized Patients Admitted to the Integrated Medicine Ward
Who may be able to join
- Hospitalized Patients Admitted to the Integrated Medicine Ward
Who cannot join
- pregnant woman
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Point-of-care Ultrasonography(POCUS)
This research project aims to establish a real-time focused ultrasound examination protocol for routine assessment of hospitalized patients, including evaluations of the inferior vena cava (IVC), pericardial effusion, hydronephrosis, and ascites.
Read the detailed description
The primary objective is to investigate the clinical benefits of implementing a real-time focused ultrasound protocol for inpatients. These benefits include improved diagnostic accuracy, enhanced examination safety, better treatment outcomes, reduced length of hospital stay, and a comparison of hospitalization duration, ultimately leading to lower healthcare costs and reduced pressure on hospital resources. Through this study, we aim to gain a deeper understanding of the clinical value of this technology and provide a valuable assessment tool to improve the care and management of hospitalized patients.
- Conditions
- Heart Failure, Congestive, Renal Failure Acute Chronic, Liver Cirrhosis, Sepsis, Edema, Pulmonary, Establish a Real-time Focused Ultrasound Examination Protocol for Routine Assessment of Hospitalized Patients
- Keywords
- POCUS, heart failure, renal failure, liver cirrhosis, dyspnea, edema, sepsis
- Medical subject headings
- Heart Failure, Liver Cirrhosis, Sepsis, Pulmonary Edema, Edema, Renal Insufficiency, Dyspnea
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean Length of Hospital Stay in Days
Length of hospital stay will be measured as the number of days from hospital admission to hospital discharge during the index hospitalization. The mean length of stay will be compared between patients with documented point-of-care ultrasound assessment and patients without documented point-of-care ultrasound assessment.
Measured: From admission to discharge during the index hospitalization, up to 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2026
- Study start5 Apr 2025
- Primary completion17 Apr 2026
- Study completion5 Apr 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Heart Failure, CongestiveStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 9,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07656428
- Sponsor's protocol ID
- 202404079RINA
- Status last verified
- Jun 2026
- First submitted
- 6 Apr 2025
- Last updated
- 18 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J. Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J. 2017 Dec;9(1):7. doi: 10.1186/s13089-017-0062-3. Epub 2017 Mar 7.
PubMed 28271386Koratala A, Ronco C, Kazory A. Multi-Organ Point-Of-Care Ultrasound in Acute Kidney Injury. Blood Purif. 2022;51(12):967-971. doi: 10.1159/000522652. Epub 2022 Mar 18.
PubMed 35306497Blaivas M, Adhikari S, Savitsky EA, Blaivas LN, Liu YT. Artificial intelligence versus expert: a comparison of rapid visual inferior vena cava collapsibility assessment between POCUS experts and a deep learning algorithm. J Am Coll Emerg Physicians Open. 2020 Jul 31;1(5):857-864. doi: 10.1002/emp2.12206. eCollection 2020 Oct.
PubMed 33145532Alonso JV, Turpie J, Farhad I, Ruffino G. Protocols for Point-of-Care-Ultrasound (POCUS) in a Patient with Sepsis; An Algorithmic Approach. Bull Emerg Trauma. 2019 Jan;7(1):67-71. doi: 10.29252/beat-0701010. No abstract available.
PubMed 30719469Abu-Zidan FM, Cevik AA. Diagnostic point-of-care ultrasound (POCUS) for gastrointestinal pathology: state of the art from basics to advanced. World J Emerg Surg. 2018 Oct 15;13:47. doi: 10.1186/s13017-018-0209-y. eCollection 2018.
PubMed 30356808Alerhand S, Adrian RJ, Long B, Avila J. Pericardial tamponade: A comprehensive emergency medicine and echocardiography review. Am J Emerg Med. 2022 Aug;58:159-174. doi: 10.1016/j.ajem.2022.05.001. Epub 2022 May 6.
PubMed 35696801
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Point-of-care Ultrasonography(POCUS)
- ClinicalTrials.gov ID
- NCT07656428
- Acronym / sponsor ID
- 202404079RINA
- Conditions
- Heart Failure, Congestive, Renal Failure Acute Chronic, Liver Cirrhosis, Sepsis, Edema, Pulmonary, Establish a Real-time Focused Ultrasound Examination Protocol for Routine Assessment of Hospitalized Patients
- Keywords
- POCUS, heart failure, renal failure, liver cirrhosis, dyspnea, edema, sepsis
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 9,000 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 5 Apr 2025 (actual)
- Primary completion
- 17 Apr 2026 (actual)
- Study completion
- 5 Apr 2035 (estimated)
- First posted
- 18 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research project aims to establish a real-time focused ultrasound examination protocol for routine assessment of hospitalized patients, including evaluations of the inferior vena cava (IVC), pericardial effusion, hydronephrosis, and ascites.
Detailed description
The primary objective is to investigate the clinical benefits of implementing a real-time focused ultrasound protocol for inpatients. These benefits include improved diagnostic accuracy, enhanced examination safety, better treatment outcomes, reduced length of hospital stay, and a comparison of hospitalization duration, ultimately leading to lower healthcare costs and reduced pressure on hospital resources. Through this study, we aim to gain a deeper understanding of the clinical value of this technology and provide a valuable assessment tool to improve the care and management of hospitalized patients.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Hospitalized Patients Admitted to the Integrated Medicine Ward
Key inclusion criteria (1 listed)
- Hospitalized Patients Admitted to the Integrated Medicine Ward
Key exclusion criteria (1 listed)
- pregnant woman
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mean Length of Hospital Stay in Days
Time frame: From admission to discharge during the index hospitalization, up to 90 days
Length of hospital stay will be measured as the number of days from hospital admission to hospital discharge during the index hospitalization. The mean length of stay will be compared between patients with documented point-of-care ultrasound assessment and patients without documented point-of-care ultrasound assessment.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2026.
- Results publication: PubMed 28271386Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J. Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J. 2017 Dec;9(1):7. doi: 10.1186/s13089-017-0062-3. Epub 2017 Mar 7.
- Results publication: PubMed 35306497Koratala A, Ronco C, Kazory A. Multi-Organ Point-Of-Care Ultrasound in Acute Kidney Injury. Blood Purif. 2022;51(12):967-971. doi: 10.1159/000522652. Epub 2022 Mar 18.
- Results publication: PubMed 33145532Blaivas M, Adhikari S, Savitsky EA, Blaivas LN, Liu YT. Artificial intelligence versus expert: a comparison of rapid visual inferior vena cava collapsibility assessment between POCUS experts and a deep learning algorithm. J Am Coll Emerg Physicians Open. 2020 Jul 31;1(5):857-864. doi: 10.1002/emp2.12206. eCollection 2020 Oct.
- Results publication: PubMed 30719469Alonso JV, Turpie J, Farhad I, Ruffino G. Protocols for Point-of-Care-Ultrasound (POCUS) in a Patient with Sepsis; An Algorithmic Approach. Bull Emerg Trauma. 2019 Jan;7(1):67-71. doi: 10.29252/beat-0701010. No abstract available.
- Results publication: PubMed 30356808Abu-Zidan FM, Cevik AA. Diagnostic point-of-care ultrasound (POCUS) for gastrointestinal pathology: state of the art from basics to advanced. World J Emerg Surg. 2018 Oct 15;13:47. doi: 10.1186/s13017-018-0209-y. eCollection 2018.
- Results publication: PubMed 35696801Alerhand S, Adrian RJ, Long B, Avila J. Pericardial tamponade: A comprehensive emergency medicine and echocardiography review. Am J Emerg Med. 2022 Aug;58:159-174. doi: 10.1016/j.ajem.2022.05.001. Epub 2022 May 6.
- Individual participant dataSharing planned: No
Related trials for Heart Failure, Congestive
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Failure, Congestive and Renal Failure Acute Chronic, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean Length of Hospital Stay in Days (time frame: From admission to discharge during the index hospitalization, up to 90 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07656428, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.